Aerts et al. [19] proved in an animal study that in vivo imaging of 89Zr-cetuximab is feasible and also showed a disparity between 89Zr-cetuximab uptake and EGFR-expression of the tumor cells. This evidence concerns the gene EGFR and neoplasm.